[Federal Register Volume 74, Number 140 (Thursday, July 23, 2009)]
[Notices]
[Pages 36494-36495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-17519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC); 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates:
    8:30 a.m.-5 p.m., September 2, 2009.
    8:30 a.m.-3 p.m., September 3, 2009.
    Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global 
Communications Center, Building 19, Room 232, Auditorium B, Atlanta, 
Georgia 30333.
    New Information--Online Registration Required: In order to 
expedite the security clearance process at the CDC Roybal Campus 
located on Clifton Road, all CLIAC attendees are required to 
register for the meeting online at least 14 days in advance at 
http://wwwn.cdc.gov/cliac/default.aspx by clicking the ``Register 
for a Meeting'' link and completing all forms according to the 
instructions given. Please complete all the required fields before 
submitting your registration and submit no later than August 19, 
2009.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact on medical and laboratory practice of proposed revisions to 
the standards; and the modification of the standards to accommodate 
technological advances.
    Matters To Be Discussed: The agenda will include agency updates 
from the CDC, the Centers for Medicare & Medicaid Services,

[[Page 36495]]

and the Food and Drug Administration; and presentations and 
discussion that address assuring laboratory testing quality during 
public health emergencies, assessing the performance and impact of 
waived testing, and the current state of HIV testing. Agenda items 
are subject to change as priorities dictate.
    Providing Oral or Written Comments: It is the policy of CLIAC to 
accept written public comments and provide a brief period for oral 
public comments whenever possible.
    Oral Comments: In general, each individual or group requesting 
to make an oral presentation will be limited to a total time of five 
minutes (unless otherwise indicated). Speakers must also submit 
their comments in writing for inclusion in the meeting's Summary 
Report. To assure adequate time is scheduled for public comments, 
individuals or groups planning to make an oral presentation should, 
when possible, notify the contact person below at least one week 
prior to the meeting date.
    Written Comments: For individuals or groups unable to attend the 
meeting, CLIAC accepts written comments until the date of the 
meeting (unless otherwise stated). However, the comments should be 
received at least one week prior to the meeting date so that the 
comments may be made available to the Committee for their 
consideration and public distribution. Written comments, one hard 
copy with original signature, should be provided to the contact 
person below. Written comments will be included in the meeting's 
Summary Report.
    Contact Person for Additional Information: Nancy Anderson, 
Chief, Laboratory Practice Standards Branch, Division of Laboratory 
Systems, National Center for Preparedness, Detection, and Control of 
Infectious Diseases, Coordinating Center for Infectious Diseases, 
CDC, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; 
Telephone (404) 498-2471; Fax (404) 498-2215; or via e-mail at 
<a href="/cdn-cgi/l/email-protection#95dbf4fbf6ecbbd4fbf1f0e7e6fafbd5f6f1f6bbfdfde6bbf2fae3"><span class="__cf_email__" data-cfemail="6d230c030e14432c0309081f1e02032d0e090e4305051e430a021b">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: July 15, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-17519 Filed 7-22-09; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>